-
1
-
-
0033172779
-
Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999
-
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 736-755
-
-
-
3
-
-
0030900530
-
Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy
-
Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111:623-631. (Pubitemid 27132936)
-
(1997)
Chest
, vol.111
, Issue.3
, pp. 623-631
-
-
Gottlieb, J.E.1
Israel, H.L.2
Steiner, R.M.3
Triolo, J.4
Patrick, H.5
-
4
-
-
77955043019
-
The etiologic role of infectious antigens in sarcoidosis pathogenesis
-
Oswald-Richter KA, Drake WP. The etiologic role of infectious antigens in sarcoidosis pathogenesis. Semin Respir Crit Care Med 2010; 31:375-379.
-
(2010)
Semin Respir Crit Care Med
, vol.31
, pp. 375-379
-
-
Oswald-Richter, K.A.1
Drake, W.P.2
-
6
-
-
33745264450
-
Natural history of hepatic sarcoidosis and its response to treatment
-
Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006; 18:721-726.
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, pp. 721-726
-
-
Kennedy, P.T.1
Zakaria, N.2
Modawi, S.B.3
-
7
-
-
58149384455
-
Gastrointestinal and hepatic manifestations of sarcoidosis
-
quiz 3193
-
Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103:3184-3192; quiz 3193.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 3184-3192
-
-
Ebert, E.C.1
Kierson, M.2
Hagspiel, K.D.3
-
9
-
-
44649145277
-
Hepatic, ocular, and cutaneous sarcoidosis
-
DOI 10.1016/j.ccm.2008.03.008, PII S027252310800035X
-
Rose AS, Tielker MA, Knox KS. Hepatic, ocular, and cutaneous sarcoidosis. Clin Chest Med 2008; 29:509-524; ix. (Pubitemid 351778208)
-
(2008)
Clinics in Chest Medicine
, vol.29
, Issue.3
, pp. 509-524
-
-
Rose, A.S.1
Tielker, M.A.2
Knox, K.S.3
-
10
-
-
0036914146
-
Hepatic, splenic, and gastrointestinal involvement with sarcoidosis
-
DOI 10.1055/s-2002-36517
-
Judson MA. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 2002; 23:529-541. (Pubitemid 36026366)
-
(2002)
Seminars in Respiratory and Critical Care Medicine
, vol.23
, Issue.6
, pp. 529-541
-
-
Judson, M.A.1
-
11
-
-
10644294658
-
A case control etiologic study of sarcoidosis: Environmental and occupational risk factors
-
DOI 10.1164/rccm.200402-249OC
-
Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170:1324-1330. (Pubitemid 39657197)
-
(2004)
American Journal of Respiratory and Critical Care Medicine
, vol.170
, Issue.12
, pp. 1324-1330
-
-
Newman, L.S.1
Rose, C.S.2
Bresnitz, E.A.3
Rossman, M.D.4
Barnard, J.5
Frederick, M.6
Terrin, M.L.7
Weinberger, S.E.8
Moller, D.R.9
McLennan, G.10
Hunninghake, G.11
DePalo, L.12
Baughman, R.P.13
Iannuzzi, M.C.14
Judson, M.A.15
Knatterud, G.L.16
Thompson, B.W.17
Teirstein, A.S.18
Yeager Jr., H.19
Johns, C.J.20
Rabin, D.L.21
Rybicki, B.A.22
Cherniack, R.23
more..
-
12
-
-
34748908099
-
Hepatobiliary disease in sarcoidosis
-
Kahi CJ, Saxena R, Temkit M, et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:117-123. (Pubitemid 47471830)
-
(2006)
Sarcoidosis Vasculitis and Diffuse Lung Diseases
, vol.23
, Issue.2
, pp. 117-123
-
-
Kahi, C.J.1
Saxena, R.2
Temkit, M.3
Canlas, K.4
Roberts, S.5
Knox, K.6
Wilkes, D.7
Kwo, P.Y.8
-
13
-
-
0034424752
-
Hepatic granulomas and hepatic sarcoidosis
-
ix-x
-
Valla DC, Benhamou JP. Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis 2000; 4:269-285; ix-x.
-
(2000)
Clin Liver Dis
, vol.4
, pp. 269-285
-
-
Valla, D.C.1
Benhamou, J.P.2
-
14
-
-
84859910080
-
Disseminated sarcoidosis presenting as granulomatous gastritis: A clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis
-
Epub ahead of print
-
Dulai PS, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol 2012. [Epub ahead of print]
-
(2012)
J Clin Gastroenterol
-
-
Dulai, P.S.1
Rothstein, R.I.2
-
16
-
-
0029065210
-
Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases
-
Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995; 195:757-762.
-
(1995)
Radiology
, vol.195
, pp. 757-762
-
-
Warshauer, D.M.1
Molina, P.L.2
Hamman, S.M.3
-
18
-
-
0027436223
-
Hepatic sarcoidosis: Clinicopathologic features in 100 patients
-
DOI 10.1097/00000478-199312000-00009
-
Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993; 17:1272-1280. (Pubitemid 23344632)
-
(1993)
American Journal of Surgical Pathology
, vol.17
, Issue.12
, pp. 1272-1280
-
-
Devaney, K.1
Goodman, Z.D.2
Epstein, M.S.3
Zimmerman, H.J.4
Ishak, K.G.5
-
19
-
-
0033645047
-
Hepatic sarcoidosis: Clinicopathologic features in thirty-seven patients
-
Bilir M, Mert A, Ozaras R, et al. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000; 31:337-338.
-
(2000)
J Clin Gastroenterol
, vol.31
, pp. 337-338
-
-
Bilir, M.1
Mert, A.2
Ozaras, R.3
-
21
-
-
0030896101
-
Course of asymptomatic liver involvement in sarcoidosis: Role of therapy in selected cases
-
Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:73-76. (Pubitemid 27170558)
-
(1997)
Sarcoidosis Vasculitis and Diffuse Lung Disease
, vol.14
, Issue.1
, pp. 73-76
-
-
Vatti, R.1
Sharma, O.P.2
-
22
-
-
0037244516
-
Treatment of sarcoidosis - From a basic science point of view
-
DOI 10.1046/j.1365-2796.2003.01075.x
-
Moller DR. Treatment of sarcoidosis: from a basic science point of view. J Intern Med 2003; 253:31-40. (Pubitemid 36120995)
-
(2003)
Journal of Internal Medicine
, vol.253
, Issue.1
, pp. 31-40
-
-
Moller, D.R.1
-
24
-
-
0014844763
-
Sarcoidosis and chronic hepatic disease: A clinical and pathologic study of 20 patients
-
Maddrey WC, Johns CJ, Boitnott JK, Iber FL. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine 1970; 49:375-395.
-
(1970)
Medicine
, vol.49
, pp. 375-395
-
-
Maddrey, W.C.1
Johns, C.J.2
Boitnott, J.K.3
Iber, F.L.4
-
25
-
-
59349092007
-
Antioxidant status associated with inflammation in sarcoidosis: A potential role for antioxidants
-
Boots AW, Drent M, Swennen EL, et al. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med 2009; 103:364-372.
-
(2009)
Respir Med
, vol.103
, pp. 364-372
-
-
Boots, A.W.1
Drent, M.2
Swennen, E.L.3
-
26
-
-
79952622786
-
Butyrophilin-like 2 in pulmonary sarcoidosis: A factor for susceptibility and progression?
-
Wijnen PA, Voorter CE, Nelemans PJ, et al. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum Immunol 2011; 72:342-347.
-
(2011)
Hum Immunol
, vol.72
, pp. 342-347
-
-
Wijnen, P.A.1
Voorter, C.E.2
Nelemans, P.J.3
-
27
-
-
76249084043
-
The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis
-
Wijnen PA, Nelemans PJ, Verschakelen JA, et al. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue antigens 2010; 75:262-268.
-
(2010)
Tissue Antigens
, vol.75
, pp. 262-268
-
-
Wijnen, P.A.1
Nelemans, P.J.2
Verschakelen, J.A.3
-
28
-
-
23944435405
-
The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites
-
DOI 10.1086/444435
-
Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 2005; 77:491-499. (Pubitemid 41192655)
-
(2005)
American Journal of Human Genetics
, vol.77
, Issue.3
, pp. 491-499
-
-
Rybicki, B.A.1
Walewski, J.L.2
Maliarik, M.J.3
Kian, H.4
Iannuzzi, M.C.5
-
29
-
-
33748855564
-
Comparison of sarcoidosis phenotypes among affected African-American siblings
-
DOI 10.1378/chest.130.3.855
-
Judson MA, Hirst K, Iyengar SK, et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 2006; 130:855-862. (Pubitemid 44423620)
-
(2006)
Chest
, vol.130
, Issue.3
, pp. 855-862
-
-
Judson, M.A.1
Hirst, K.2
Iyengar, S.K.3
Rybicki, B.A.4
El Ghormli, L.5
Baughman, R.P.6
Donohue, J.F.7
Elston, R.C.8
Kavuru, M.S.9
Moller, D.R.10
Newman, L.S.11
Rabin, D.L.12
Rossman, M.D.13
Teirstein, A.S.14
Iannuzzi, M.C.15
-
30
-
-
34548725164
-
Potential etiologic agents in sarcoidosis
-
DOI 10.1513/pats.200608-155MS
-
Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 2007; 4:465-468. (Pubitemid 47435374)
-
(2007)
Proceedings of the American Thoracic Society
, vol.4
, Issue.5
, pp. 465-468
-
-
Moller, D.R.1
-
31
-
-
46449100060
-
Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis
-
DOI 10.1185/03007990802133377
-
Uzun H, Yanardag H, Gelisgen R, et al. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis. Curr Med Res Opin 2008; 24:1651-1657. (Pubitemid 351929063)
-
(2008)
Current Medical Research and Opinion
, vol.24
, Issue.6
, pp. 1651-1657
-
-
Uzun, H.1
Yanardag, H.2
Gelisgen, R.3
Genc, H.4
Uygun, S.5
Vehid, S.6
Karter, Y.7
Demirci, S.8
-
32
-
-
79960691818
-
Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis
-
Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr 2011; 30:506-512.
-
(2011)
Clin Nutr
, vol.30
, pp. 506-512
-
-
Boots, A.W.1
Drent, M.2
De Boer, V.C.3
-
33
-
-
0036710706
-
Oxidative stress, transcription factors and chromatin remodelling in lung inflammation
-
DOI 10.1016/S0006-2952(02)01153-X, PII S000629520201153X
-
Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 2002; 64:935-942. (Pubitemid 35232267)
-
(2002)
Biochemical Pharmacology
, vol.64
, Issue.5-6
, pp. 935-942
-
-
Rahman, I.1
-
34
-
-
0035840849
-
Oxidative stress and lung inflammation in airways disease
-
DOI 10.1016/S0014-2999(01)01320-6, PII S0014299901013206
-
MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429:195-207. (Pubitemid 33043996)
-
(2001)
European Journal of Pharmacology
, vol.429
, Issue.1-3
, pp. 195-207
-
-
MacNee, W.1
-
36
-
-
33847787156
-
Steroid-resistant sarcoidosis: Is antagonism of TNF-alpha the answer?
-
DOI 10.1042/CS20060094
-
Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond) 2007; 112:281-289. (Pubitemid 46392115)
-
(2007)
Clinical Science
, vol.112
, Issue.5-6
, pp. 281-289
-
-
Denys, B.G.1
Bogaerts, Y.2
Coenegrachts, K.L.3
De Vriese, A.S.4
-
38
-
-
0030908958
-
Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis
-
Becheur H, Dall'osto H, Chatellier G, et al. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci 1997; 42:789-791. (Pubitemid 27196031)
-
(1997)
Digestive Diseases and Sciences
, vol.42
, Issue.4
, pp. 789-791
-
-
Becheur, H.1
Dall'osto, H.2
Chatellier, G.3
Charton-Bain, M.-C.4
Aubertin, J.-M.5
Attar, A.6
Bloch, F.7
Petite, J.-P.8
-
39
-
-
0030752668
-
The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis
-
Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997; 26:554-560. (Pubitemid 27392343)
-
(1997)
Hepatology
, vol.26
, Issue.3
, pp. 554-560
-
-
Moreno-Merlo, F.1
Wanless, I.R.2
Shimamatsu, K.3
Sherman, M.4
Greig, P.5
Chiasson, D.6
-
40
-
-
79954764140
-
A randomized controlled trial of highdose ursodesoxycholic acid for nonalcoholic steatohepatitis
-
Ratziu V, de Ledinghen V, Oberti F, et al. A randomized controlled trial of highdose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2011; 54:1011-1019.
-
(2011)
J Hepatol
, vol.54
, pp. 1011-1019
-
-
Ratziu, V.1
De Ledinghen, V.2
Oberti, F.3
-
41
-
-
14544294003
-
Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis
-
DOI 10.1007/s10620-005-1300-2
-
Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci 2005; 50:196-200. (Pubitemid 40379162)
-
(2005)
Digestive Diseases and Sciences
, vol.50
, Issue.1
, pp. 196-200
-
-
Alenezi, B.1
Lamoureux, E.2
Alpert, L.3
Szilagyi, A.4
-
42
-
-
0032720556
-
Hepatic sarcoidosis responding to chloroquine as steroid-sparing drug
-
Galwankar S, Vyas M, Desai D, Udwadia ZF. Hepatic sarcoidosis responding to chloroquine as steroid-sparing drug. Indian J Gastroenterol 1999; 18:177-178. (Pubitemid 29516872)
-
(1999)
Indian Journal of Gastroenterology
, vol.18
, Issue.4
, pp. 177-178
-
-
Galwankar, S.1
Vyas, M.2
Desai, D.3
Udwadia, Z.F.4
-
43
-
-
0021042333
-
Sarcoidosis presenting as biliary cirrhosis: Treatment with chlorambucil
-
Hughes GS Jr, Kataria YP, O'Brien TF Jr. Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J 1983; 76:1440-1442. (Pubitemid 14203663)
-
(1983)
Southern Medical Journal
, vol.76
, Issue.11
, pp. 1440-1442
-
-
Hughes Jr., G.S.1
Kataria, Y.P.2
O'Brien Jr., T.F.3
-
44
-
-
0033831246
-
Ursodeoxycholic acid treatment in abdominal sarcoidosis
-
Baratta L, Cascino A, Delfino M, et al. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci 2000; 45:1559-1562.
-
(2000)
Dig Dis Sci
, vol.45
, pp. 1559-1562
-
-
Baratta, L.1
Cascino, A.2
Delfino, M.3
-
45
-
-
57049125016
-
Hepatobiliary and pancreatic: Cirrhosis secondary to hepatic sarcoidosis
-
Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 2008; 23:1942.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 1942
-
-
Malhotra, A.1
Naniwadekar, A.2
Sood, G.3
-
47
-
-
80355138040
-
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
-
Sahoo DH, Bandyopadhyay D, Xu M, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011; 38:1145-1150.
-
(2011)
Eur Respir J
, vol.38
, pp. 1145-1150
-
-
Sahoo, D.H.1
Bandyopadhyay, D.2
Xu, M.3
-
48
-
-
0027156380
-
Clinical course after liver transplantation in patients with sarcoidosis
-
Casavilla FA, Gordon R, Wright HI, et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993; 118:865-866. (Pubitemid 23145411)
-
(1993)
Annals of Internal Medicine
, vol.118
, Issue.11
, pp. 865-866
-
-
Casavilla, F.A.1
Gordon, R.2
Wright, H.I.3
Gavaler, J.S.4
Starzl, T.E.5
Van Thiel, D.H.6
-
50
-
-
0842310884
-
Treatment of cutaneous sarcoidosis with thalidomide
-
DOI 10.1016/j.jaad.2003.07.006
-
Nguyen YT, Dupuy A, Cordoliani F, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004; 50:235-241. (Pubitemid 38174281)
-
(2004)
Journal of the American Academy of Dermatology
, vol.50
, Issue.2
, pp. 235-241
-
-
Nguyen, Y.T.1
Dupuy, A.2
Cordoliani, F.3
Vignon-Pennamen, M.D.4
Lebbe, C.5
Morel, P.6
Rybojad, M.7
-
51
-
-
0346850596
-
Successful Tumor Necrosis Factor alpha Blockade Treatment in Therapy-Resistant Sarcoidosis
-
DOI 10.1002/art.11357
-
Ulbricht KU, Stoll M, Bierwirth J, et al. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003; 48:3542-3543. (Pubitemid 37531922)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.12
, pp. 3542-3543
-
-
Ulbricht, K.U.1
Stoll, M.2
Bierwirth, J.3
Witte, T.4
Schmidt, R.E.5
-
52
-
-
15844414943
-
Treatment of sarcoidosis with infliximab
-
DOI 10.1378/chest.127.3.1064
-
Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127:1064-1071. (Pubitemid 40775543)
-
(2005)
Chest
, vol.127
, Issue.3
, pp. 1064-1071
-
-
Doty, J.D.1
Mazur, J.E.2
Judson, M.A.3
-
53
-
-
33749488305
-
Effectiveness of infliximab in treating selected patients with sarcoidosis
-
DOI 10.1016/j.rmed.2006.02.017, PII S0954611106000679
-
Saleh S, Ghodsian S, Yakimova V, et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006; 100:2053-2059. (Pubitemid 44514944)
-
(2006)
Respiratory Medicine
, vol.100
, Issue.11
, pp. 2053-2059
-
-
Saleh, S.1
Ghodsian, S.2
Yakimova, V.3
Henderson, J.4
Sharma, O.P.5
-
54
-
-
49649098822
-
Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
-
Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31:1189-1196.
-
(2008)
Eur Respir J
, vol.31
, pp. 1189-1196
-
-
Judson, M.A.1
Baughman, R.P.2
Costabel, U.3
-
55
-
-
0037429638
-
Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis
-
DOI 10.1001/archinte.163.5.615
-
Baughman RP, Koehler A, Bejarano PA, et al. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 2003; 163:615-620. (Pubitemid 36314350)
-
(2003)
Archives of Internal Medicine
, vol.163
, Issue.5
, pp. 615-620
-
-
Baughman, R.P.1
Koehler, A.2
Bejarano, P.A.3
Lower, E.E.4
Weber Jr., F.L.5
-
56
-
-
4344679827
-
Pulmonary sarcoidosis
-
DOI 10.1016/j.ccm.2004.04.006, PII S0272523104000504
-
Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004; 25:521-530; vi. (Pubitemid 39149799)
-
(2004)
Clinics in Chest Medicine
, vol.25
, Issue.3
, pp. 521-530
-
-
Baughman, R.P.1
-
57
-
-
0023805363
-
Sarcoidosis. Usual and unusual manifestations
-
Baughman RP. Sarcoidosis. Usual and unusual manifestations. Chest 1988; 94:165-170.
-
(1988)
Chest
, vol.94
, pp. 165-170
-
-
Baughman, R.P.1
-
58
-
-
0017859628
-
Granulomatous Biliary Tract Obstruction due to Sarcoidosis. Report of a case and review of the literature
-
Bloom R, Sybert A, Mascatello VJ. Granulomatous biliary tract obstruction due to sarcoidosis. Report of a case and review of the literature. Am J Respir Dis 1978; 117:783-787. (Pubitemid 8334985)
-
(1978)
American Review of Respiratory Disease
, vol.117
, Issue.4
, pp. 783-787
-
-
Bloom, R.1
Sybert, A.2
Mascatello, V.J.3
-
61
-
-
66749086530
-
TPMT testing before azathioprine therapy?
-
Wan Y. TPMT testing before azathioprine therapy? Drug Ther Bull 2009; 47:9-12.
-
(2009)
Drug Ther Bull
, vol.47
, pp. 9-12
-
-
Wan, Y.1
-
62
-
-
0037242825
-
Difficult treatment issues in sarcoidosis
-
DOI 10.1046/j.1365-2796.2003.01076.x
-
Baughman RP, Lynch JP. Difficult treatment issues in sarcoidosis. J Intern Med 2003; 253:41-45. (Pubitemid 36120996)
-
(2003)
Journal of Internal Medicine
, vol.253
, Issue.1
, pp. 41-45
-
-
Baughman, R.P.1
Lynch, J.P.2
-
63
-
-
77949874647
-
Thiopurine S-methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: A pharmacogenetic cost-effectiveness analysis
-
Hagaman JT, Kinder BW, Eckman MH. Thiopurine S-methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis. Lung 2010; 188:125-132.
-
(2010)
Lung
, vol.188
, pp. 125-132
-
-
Hagaman, J.T.1
Kinder, B.W.2
Eckman, M.H.3
-
64
-
-
0024339093
-
HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation
-
Moller B, Hopf U, Stemerowicz R, et al. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology 1989; 10:179-185. (Pubitemid 19190208)
-
(1989)
Hepatology
, vol.10
, Issue.2
, pp. 179-185
-
-
Moller, B.1
Hopf, U.2
Stemerowicz, R.3
Henze, G.4
Gelderblom, H.5
-
65
-
-
0026315404
-
Methotrexate and histologic hepatic abnormalities: A meta-analysis
-
Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 1991; 90:711-716.
-
(1991)
Am J Med
, vol.90
, pp. 711-716
-
-
Whiting-O'keefe, Q.E.1
Fye, K.H.2
Sack, K.D.3
-
66
-
-
81155133749
-
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
-
Mostard RL, Voo S, van Kroonenburgh MJ, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 2011; 105:1917-1924.
-
(2011)
Respir Med
, vol.105
, pp. 1917-1924
-
-
Mostard, R.L.1
Voo, S.2
Van Kroonenburgh, M.J.3
-
68
-
-
84864881323
-
Effect of the TNF-alpha inhibitor adalimumab in patients with recalcitrant sarcoidosis: A prospective observational study using FDG-PET
-
Epub ahead of print
-
Milman N, Graudal N, Loft A, et al. Effect of the TNF-alpha inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET. Clin Respir J 2011. [Epub ahead of print].
-
(2011)
Clin Respir J
-
-
Milman, N.1
Graudal, N.2
Loft, A.3
-
69
-
-
81455131960
-
Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review
-
Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:87-94.
-
(2011)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.28
, pp. 87-94
-
-
Treglia, G.1
Taralli, S.2
Giordano, A.3
-
70
-
-
0030752586
-
Diagnosis and management of neurological sarcoidosis
-
Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-1868. (Pubitemid 27381119)
-
(1997)
Archives of Internal Medicine
, vol.157
, Issue.16
, pp. 1864-1868
-
-
Lower, E.E.1
Broderick, J.P.2
Brott, T.G.3
Baughman, R.P.4
-
71
-
-
0242636885
-
Treatment of Corticosteroid-Resistant Neurosarcoidosis with a Short-Course Cyclophosphamide Regimen
-
DOI 10.1378/chest.124.5.2023
-
Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003; 124:2023-2026. (Pubitemid 37433608)
-
(2003)
Chest
, vol.124
, Issue.5
, pp. 2023-2026
-
-
Doty, J.D.1
Mazur, J.E.2
Judson, M.A.3
-
72
-
-
5344258973
-
Adverse effects of thalidomide administration in patients with neoplastic diseases
-
DOI 10.1016/j.amjmed.2004.03.040, PII S0002934304004309
-
Dimopoulos MA, Eleutherakis-Papaiakovou V. Adverse effects of thalidomide administration in patients with neoplastic diseases. Am J Med 2004; 117:508-515. (Pubitemid 39349589)
-
(2004)
American Journal of Medicine
, vol.117
, Issue.7
, pp. 508-515
-
-
Dimopoulos, M.A.1
Eleutherakis-Papaiakovou, V.2
-
74
-
-
80055028155
-
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
-
Zein CO, Yerian LM, Gogate P, et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 2011; 54:1610-1619.
-
(2011)
Hepatology
, vol.54
, pp. 1610-1619
-
-
Zein, C.O.1
Yerian, L.M.2
Gogate, P.3
-
75
-
-
33749447564
-
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
-
DOI 10.1164/rccm.200603-402OC
-
Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795-802. (Pubitemid 44511661)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.174
, Issue.7
, pp. 795-802
-
-
Baughman, R.P.1
Drent, M.2
Kavuru, M.3
Judson, M.A.4
Costabel, U.5
Du Bois, R.6
Albera, C.7
Brutsche, M.8
Davis, G.9
Donohue, J.F.10
Muller-Quernheim, J.11
Schlenker-Herceg, R.12
Flavin, S.13
Lo, K.H.14
Oemar, B.15
Barnathan, E.S.16
-
76
-
-
62549134888
-
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them
-
Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:76-89.
-
(2008)
Sarcoidosis Vasc Diffuse Lung Dis
, vol.25
, pp. 76-89
-
-
Baughman, R.P.1
Lower, E.E.2
Drent, M.3
-
77
-
-
0034039605
-
Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
-
Kavanaugh A, St Clair EW, McCune WJ, et al. Chimeric antitumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol 2000; 27:841-850. (Pubitemid 30389736)
-
(2000)
Journal of Rheumatology
, vol.27
, Issue.4
, pp. 841-850
-
-
Kavanaugh, A.1
St. Clair, E.W.2
McCune, W.J.3
Braakman, T.4
Lipsky, P.5
-
79
-
-
80051992028
-
Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: An analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases
-
Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl 2011; 17:1027-1034.
-
(2011)
Liver Transpl
, vol.17
, pp. 1027-1034
-
-
Vanatta, J.M.1
Modanlou, K.A.2
Dean, A.G.3
-
80
-
-
22244490672
-
Patient and graft outcomes following liver transplantation for sarcoidosis
-
DOI 10.1111/j.1399-0012.2005.00372.x
-
Lipson EJ, Fiel MI, Florman SS, Korenblat KM. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005; 19:487-491. (Pubitemid 40990658)
-
(2005)
Clinical Transplantation
, vol.19
, Issue.4
, pp. 487-491
-
-
Lipson, E.J.1
Fiel, M.I.2
Florman, S.S.3
Korenblat, K.M.4
-
81
-
-
30444455026
-
Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: A case report and review of the literature
-
DOI 10.1002/lt.20626
-
Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al. Recurrent hepatic sarcoidosis postliver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl 2005; 11:1611-1614. (Pubitemid 43072642)
-
(2005)
Liver Transplantation
, vol.11
, Issue.12
, pp. 1611-1614
-
-
Cengiz, C.1
Rodriguez-Davalos, M.2
De Boccardo, G.3
Fiel, M.I.4
Rodriguez-Laiz, G.5
Kovacevic, M.6
Emre, S.7
Schiano, T.8
-
82
-
-
0033046922
-
Sarcoidosis with selective involvement of a second liver allograft: Report of a case and review of the literature
-
Hunt J, Gordon FD, Jenkins RL, et al. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999; 12:325-328. (Pubitemid 29133855)
-
(1999)
Modern Pathology
, vol.12
, Issue.3
, pp. 325-328
-
-
Hunt, J.1
Gordon, F.D.2
Jenkins, R.L.3
Lewis, W.D.4
Khettry, U.5
-
83
-
-
84858842467
-
Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease
-
Polyzos SA, Kountouras J, Zavos C, Deretzi G. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 2012; 46:272-284.
-
(2012)
J Clin Gastroenterol
, vol.46
, pp. 272-284
-
-
Polyzos, S.A.1
Kountouras, J.2
Zavos, C.3
Deretzi, G.4
-
84
-
-
72549089785
-
Targeting the TNF-alpha pathway in sarcoidosis
-
Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010; 14:21-29.
-
(2010)
Expert Opin Ther Targets
, vol.14
, pp. 21-29
-
-
Antoniu, S.A.1
-
85
-
-
77952529040
-
A position statement on NAFLD/NASH based on the EASL 2009 special conference
-
Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53:372-384.
-
(2010)
J Hepatol
, vol.53
, pp. 372-384
-
-
Ratziu, V.1
Bellentani, S.2
Cortez-Pinto, H.3
-
86
-
-
80053951780
-
Antioxidants as therapeutic agents for liver disease
-
Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int 2011; 31:1432-1448.
-
(2011)
Liver Int
, vol.31
, pp. 1432-1448
-
-
Singal, A.K.1
Jampana, S.C.2
Weinman, S.A.3
-
87
-
-
84862517200
-
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials
-
Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55:885-904.
-
(2012)
Diabetologia
, vol.55
, pp. 885-904
-
-
Musso, G.1
Cassader, M.2
Rosina, F.3
Gambino, R.4
|